Objective: To quantify the relationship between Citrus intake and risk of cancer of the oral cavity and pharynx. Design: Systematic review and meta-analysis. Data sources: Ovid MEDLINE, EMBASE, and Web of Science were searched until September 2017. Search terms included Citrus, Citrus aurantifolia, Citrus sinensis, Citrus paradisi, Citrus fruits, Citrus fruits extract, Citrus oil, fruits, oral cancer, mouth cancer, mouth neoplasm. Study selection: The selection of studies and the systematic review were carried out in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. A pre-defined inclusion checklist resulted in the inclusion of articles which were (i) published in peer-reviewed scientific journals; (ii) English language; (iii) and included a measure of Citrus fruit intake and risk of oral and pharyngeal cancer. Studies were excluded if (i) preparations derived from other fruits were used, (ii) Citrus intake was combined with intake of other fruits; (iii) in vitro or animal models were used. We also excluded reviews, systematic reviews, meta-analyses, letters, personal opinions, conference abstracts and book chapters. Data extraction: Three reviewers independently performed the extraction of data from studies included. Results: Seventeen studies met our inclusion criteria and were included in the final review. Pooled analyses showed that those with the highest Citrus fruit intake compared to the lowest intake had a 50% reduction in risk of oral cavity and pharyngeal cancer (OR 0.50; 95% CI 0.43-0.59).
Introduction
Oral cancer accounts for over 2% of the overall burden of cancer globally, with an incidence of 300,000 cases in 2012 [1] and it is the 7th major cause of death from cancer in Europe [2] . Patients with oral cancer have a poor prognosis despite advances in treatment as they continue to present with late stage disease. Indeed, the 5-year survival rate for all oral and pharyngeal cancers is only 47% for men and 55% for women [3] .
Reducing the incidence of this disease through prevention is vital due to the high morbidity rates. Discovery of new drugs or novel therapeutic approaches, designed to prevent the development of this cancer, remains an important goal for scientists. Despite continuous development of synthetic drugs which are the basis of pharmaceutical care, the plant kingdom still remains an attractive source of novel anticancer drugs. Indeed, a large amount of anti-cancer drugs originate from natural sources [4] . Moreover, it has been demonstrated that regular consumption of fruits and vegetables may play an important role in reducing cancer risk [5] [6] [7] [8] . It is estimated that a high dietary intake of vegetables and fruits (> 400 g/day) could prevent at least 20% of all cancer cases [9, 10] . However, other studies have cast some doubts over whether their intake is really producing these cancer risk reductions [5, 11] . For instance, the results from a large European prospective cohort suggested that higher a consumption of fruit and vegetables was not associated with decreased risk of pancreatic cancer [12] .
In the last decade, numerous epidemiological studies have provided evidence to suggest that regular intake of Citrus fruits may be associated with a reduced risk of all-cancers, although significant results were obtained only for prostate and pancreatic cancers [13] . Moreover, Foschi and collaborators [14] have indicated that Citrus fruits have a protective role against cancers of the digestive and upper respiratory tract, as well as Gonzalez and co-workers who have observed an inverse dose response relationship between total Citrus fruits intake and gastric cancer risk [15] . Furthermore, Bae and co-workers have provided evidence for the protective effects of a high Citrus fruit intake on risk of both gastric [16] and pancreatic cancer [17] but no association with prostate cancer risk [18] . More recently, meta-analyses have highlighted an inverse association between Citrus fruit intake and risk of the breast [19] , bladder [20] [21] [22] and esophagus [23] cancer. In contrast, a recent systematic literature review of prospective studies showed only a marginally significant decrease in risk of esophageal cancer and a nonsignificant inverse association for gastric cardia cancer [24] .
Due to the conflicting evidence regarding the effects of Citrus fruit intake on cancer, the aim of this systematic review and meta-analysis was to quantify the relationship between Citrus fruit intake and cancer of the oral cavity and pharynx. Science (1970-present) were searched independently by two reviewers (SC and MN) for literature related to Citrus fruit intake and risk of cancer of the oral cavity and pharynx. In order to retrieve all relevant papers, no limit was placed on search time frame. The last search was performed on September 25th, 2017.
The search strategy identified studies that contained at least one keyword or Medical Subject Heading (MeSH) term from each of the following exposures: (i) Citrus, Citrus aurantifolia, Citrus sinensis, Citrus paradisi, Citrus fruits, Citrus fruits extract, Citrus oil, fruits; or any of these terms combined (ii) oral cancer, mouth cancer, mouth neoplasm. The search strategy also incorporated limits to studies conducted on humans and in English language. An example of full electronic search strategy for EMBASE is provided in Table 1 . Citations, titles and abstracts were exported into Endnote X5.
The study selection and systematic review were performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement following an a priori-established protocol registered with PROSPERO (CRD42017081718) [25] .
The reviewers (SC, MN and MMC) initially screened titles and abstracts to remove obviously irrelevant articles and screened full text articles independently to identify studies for inclusion in the systematic review. Discrepancies were resolved by discussion. Reference lists of included articles were also searched for other relevant studies. The following exclusion criteria were applied: (i) studies using preparations derived from other fruits, (ii) studies in which intake was combined with a combination of other fruits; (iii) studies carried out in in vitro or in animal models. We also excluded reviews, systematic reviews, metaanalyses, letters, personal opinions, conference abstracts and book chapters. All reviewers had previous experience with systematic reviews.
Data extraction
A standardized data collection protocol was used for gathering data: apart from results, study authors, publication year, residence of participants, age and gender distribution, study design, number of cases and controls, dietary assessment method used to measure Citrus fruit intake and outcome examined, details of the adjustment for confounders, and other variables were recorded. Corresponding authors were contacted for extra study details to enable evaluation and/or analysis if these were not reported in the articles.
Statistical analysis
Meta-analyses were conducted by comparing cancer risk in the highest reported category of Citrus fruit intake with that in the lowest reported category. Adjusted odds ratios (ORs) and 95% CIs were combined and weighted to produce pooled ORs using a random-effects model, to account for heterogeneity between studies. The extent of heterogeneity in the pooled estimates was investigated using the chisquared test and the I 2 statistic: larger I 2 values indicate greater heterogeneity [26] . Separate analyses were conducted for case-control and cohort studies. Risk of publication and selection bias was evaluated by checking for asymmetry in the funnel plots of the study OR against the standard error of the logarithm of the OR [27] . Statistical analysis was conducted using Stata 14.2 (StataCorp LP, Texas, USA). 
Results
The flowchart for study selection is shown in Fig. 1 . Following initial screening of 481 titles (397 after removal of duplicates) we identified 41 full text articles for review, of which 17 were included that examined the relationship between Citrus fruit intake and risk of cancer of the oral cavity and pharynx.
Articles excluded because they were conference abstracts or book chapters were n = 16. Records excluded after title and abstract screen were n = 340. Articles excluded after full text review were n = 24: one because it was a review, one because it was a commentary, twenty-one because the Authors tested the effects of fruits intake not specifying if they were Citrus fruits. The paper of Grideley and co-workers (1990) was excluded because the Authors did not report the confidence interval values [28] .
The characteristic of studies investigating Citrus fruit intake and the risk of oral cavity and pharynx cancers are shown in Tables 2 and 3 . Most of the included studies (n = 15) originated from hospital-based case-control studies [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] , only two studies are cohort studies [44, 45] and all included studies utilized food frequency questionnaires to measure dietary intake (Tables 2 and 3 ). Most studies adjusted for age, sex, smoking status, alcohol use and education level; some also accounted for energy intake and body mass index (BMI) ( Table 4) . Adjustment for other confounders varied between studies (Table 4) . Fig. 2 shows the results for all studies comparing the risk of oral cavity and pharyngeal cancer in those with the highest versus the lowest intake of Citrus fruit. The pooled risk estimate using the random-effects model showed a 50% statistically significant reduction in risk of oral cavity and pharyngeal cancers associated with Citrus fruit intake (OR 0.50; 95% CI 0.43-0.59).
There was moderate heterogeneity between the studies I 2 = 43.9%; P = 0.024, but this was not statistically significant. No clear evidence of publication bias was found on visual inspection of the funnel plot (Fig. 3) . The protective effect of Citrus fruit was much stronger in case-control studies than in cohort studies only. In particular, the pooled risk of case-control studies showed a 53% statistically significant reduction in risk of oral cavity and pharyngeal cancers associated with Citrus fruit intake (OR 0.47; 95% CI 0.40-0.55) (Fig. 4) while the reduction of risk in cohort studies was 27% (OR 0.73; 95% CI 0.55-0.96) (Fig. 5) . The heterogeneity was reduced in stratified analysis by study design (I 2 = 36.3%; P = 0.073 and I 2 = 0%; P = 0.806 for case-control and cohort studies, respectively) (Figs. 4 and 5 ).
Discussion
We investigated the association between Citrus fruit intake and the risk of oral cancer using a meta-analysis of existing epidemiologic studies. To the best of our knowledge, this is the first systematic review and meta-analysis of oral cancer and Citrus fruit intake. The major finding of the study suggests that dietary intake of Citrus fruits plays an Fig. 3 . Funnel plot of studies evaluating the association between Citrus fruit intake and risk of cancer of the oral cavity and pharynx. Dotted lines indicate the 95% pseudo-confidence intervals. SE = standard error; OR = odds ratio. Fig. 4 . Meta-analysis of risk of oral cancer in the highest versus lowest category of Citrus intake (case-control studies).°Test for heterogeneity: χ 2 = 23.54, df = 15, P = 0.073; I 2 = 36.3%. *man; **woman.
important protective role in the prevention of oral cancer with a pooled OR 0.50 (95% CI 0.43-0.59) for those in the highest category of intake. A higher Citrus fruit intake has also been shown to be inversely associated with cancer at other site such as stomach, pancreas, breast, bladder and oesophagus [15, 17, 19, 20, 23] . Only 8 papers (47%), among all taken into account, display a dose-response relationship [30, 32, 33, 37, [39] [40] [41] 43] . The main limitation of this meta-analysis is that almost all the studies were hospital-based case-control studies; it is likely therefore that Citrus fruit intake will have been influenced by recall bias and it is not possible to demonstrate a temporal relationship between Citrus fruit intake and oral cancer risk. In addition, the use hospital-based controls may have affected the results of individual studies, as they are unlikely to be representative of healthy controls.
A random-effects model was used to pool the results from individual studies to account for heterogeneity between the studies included. In addition, although all the selected studies had collected information on factors considered to be potential confounders, such as demographic characteristics, smoking, alcohol, BMI and energy intake, the factors adjusted for the individual analyses of Citrus fruit intake varied.
There are numerous biologically plausible mechanisms whereby Citrus fruit intake may affect cancer risk. For example, Citrus fruits are rich in vitamin C that has been investigated since the early 1980′s in epidemiological studies on upper aero-digestive tract cancer, with the most of the studies demonstrating inverse associations [46, 47] . Among possible mechanisms of anti-cancer action, vitamin C has been hypothesized to counteract inflammation and subsequent oxidative damage to DNA, which play a role in the initiation and progression of cancer. Moreover, due to its pro-oxidant capacity, vitamin C can act as cancer cells killer [48, 49] . Furthermore, this nutrient may act synergistically with other biological antioxidants and radical scavengers in quenching different elements of a radical cascade. This might also support the strongest evidence in favour of fruit and vegetables, as compared to that focusing on nutrients [50, 51] .
In addition to high vitamin C content, Citrus fruits contain a wide range of bioactive compounds, such as flavonoids, carotenoids, and limonoids. The flavonoids from Citrus fruits have been shown to have a protective effect against oxidative stress, inflammation, infection, cardiovascular disease, neurodegenerative disease and some types of cancer [52] [53] [54] [55] [56] . It is likely that Citrus fruits reduce cancer risk by inhibition of oxidative stress and oxidative damage and by interfering with the initiation, promotion, and progression of cancer [57] . It is inconclusive whether the antitumor effect of polyphenols is related to their antioxidant effects, however flavonoids which have superior free radical scavenging properties are more effective antioxidants than vitamin C, vitamin E, and carotenoids [58] .
In the last two decades, numerous pre-clinical studies have documented the anti-proliferative activity of flavonoids, which has been largely linked to their abilities to interact with specific intracellular signalling pathways, in addition to their well-known antioxidant capacity [57, [59] [60] [61] [62] [63] [64] . In this field, recently, we have reported the anticancer activity of Citrus bergamia (bergamot) juice (BJ) in different in vitro [65, 66] and in vivo [67] models, and have proposed that its flavonoid content is responsible for this action [68] . We have also shown the anti-proliferative effects of a flavonoid-rich extract from mandarin juice on human anaplastic thyroid carcinoma cells [69] and the proapoptotic activity of essential oils extracted from the peel of bergamot fruits [70] . However, the majority of experimental studies aimed to evaluate the anti-cancer effect of Citrus juices have been performed in vivo [71] [72] [73] [74] .
In conclusion, on the basis of current epidemiologic evidence, we found that the consumption of Citrus fruits was associated with a reduced risk of oral cancer. Prospective studies, which are less prone to recall and selection bias, are needed to confirm this result. Data from in vitro and in vivo studies suggest that particular subtypes of Citrus fruit may affect cancer risk differently and so further epidemiological research is required to examine these relationships in humans.This would provide the data necessary to develop a novel therapeutic approach, using Citrus fruits to prevent the development of oral cancer perhaps in high-risk groups such as smokers and heavy drinkers of alcohol.
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